| APD AIR PRODS & CHEMS INC | Q1 2014 | 9 of 169 | 4.8% | 7.7% | 8 | Exited by Q1 2021 | +148% |
| NEE NEXTERA ENERGY INC | Q2 2014 | 5 of 182 | 4.9% | 6.5% | 5 | Exited by Q3 2015 | −4.3% |
| ASH ASHLAND INC NEW | Q2 2014 | 12 of 129 | 1.3% | 2.2% | 2 | Exited by Q4 2014 | −4.3% |
| PEP PEPSICO INC | Q2 2014 | 14 of 139 | 2.6% | 2.7% | 2 | Exited by Q4 2014 | +4.2% |
| PPG PPG INDS INC | Q3 2014 | 2 of 138 | 1.9% | 5.3% | 6 | Exited by Q1 2017 | −3.7% |
| MDT MEDTRONIC PLC | Q3 2014 | 10 of 173 | 3.1% | 4.2% | 26 | Exited by Q2 2026 | +40% |
| CDK CDK GLOBAL INC | Q4 2014 | 5 of 139 | 3.7% | 3.7% | 2 | Exited by Q2 2015 | +15% |
| MSTR MICROSTRATEGY INC | Q4 2014 | 5 of 143 | 1.3% | 1.7% | 3 | Exited by Q3 2015 | +4.7% |
| FIVE FIVE BELOW INC | Q1 2015 | 3 of 174 | 1.1% | 2.6% | 10 | Exited by Q3 2024 | +206% |
| ARMK ARAMARK | Q1 2015 | 6 of 177 | 6.2% | 7.6% | 9 | Exited by Q4 2019 | +38% |
| NXPI NXP SEMICONDUCTORS N V | Q1 2015 | 16 of 228 | 3.8% | 3.9% | 5 | Exited by Q4 2021 | +95% |
| QSR RESTAURANT BRANDS INTL INC | Q2 2015 | 13 of 176 | 3.4% | 11.1% | 18 | Exited by Q4 2019 | +86% |
| PFE PFIZER INC | Q3 2015 | 16 of 208 | 2.4% | 7.6% | 7 | Exited by Q1 2024 | −3.4% |
| GOOG ALPHABET INC | Q4 2015 | 21 of 350 | 5.0% | 9.3% | 12 | Held at last filing, Q2 2026 | +831% |
| NWL NEWELL BRANDS INC | Q2 2016 | 14 of 156 | 5.2% | 5.2% | 2 | Exited by Q4 2016 | +8.4% |
| CHTR CHARTER COMMUNICATIONS INC N | Q2 2016 | 15 of 269 | 12.4% | 12.4% | 10 | Exited by Q1 2021 | +189% |
| USFD US FOODS HLDG CORP | Q3 2016 | 7 of 183 | 1.0% | 1.9% | 6 | Held at last filing, Q2 2026 | +333% |
| OPLN KAR AUCTION SVCS INC | Q4 2016 | 13 of 132 | 0.9% | 1.8% | 5 | Exited by Q1 2018 | +19% |
| CRM SALESFORCE INC | Q4 2016 | 18 of 303 | 1.4% | 17.1% | 17 | Exited by Q1 2026 | +287% |
| UNH UNITEDHEALTH GROUP INC | Q4 2016 | 26 of 299 | 1.7% | 5.7% | 31 | Held at last filing, Q2 2026 | +160% |
| CPRT COPART INC | Q1 2017 | 12 of 178 | 0.4% | 2.9% | 15 | Exited by Q1 2022 | +390% |
| FMC F M C CORP | Q1 2017 | 12 of 157 | 2.3% | 7.0% | 7 | Exited by Q4 2018 | +25% |
| MAR MARRIOTT INTL INC NEW | Q2 2017 | 11 of 182 | 3.2% | 3.2% | 7 | Exited by Q4 2022 | +40% |
| NSC NORFOLK SOUTHERN CORP | Q4 2017 | 21 of 205 | 2.3% | 2.5% | 6 | Exited by Q3 2020 | +21% |
| DE DEERE & CO | Q1 2018 | 15 of 185 | 2.0% | 4.8% | 5 | Exited by Q2 2020 | −11% |
| BA BOEING CO | Q1 2018 | 19 of 221 | 5.9% | 6.9% | 6 | Exited by Q1 2025 | −46% |
| PBF PBF ENERGY INC | Q2 2018 | 12 of 153 | 1.1% | 1.7% | 2 | Exited by Q4 2018 | +19% |
| BSX BOSTON SCIENTIFIC CORP | Q3 2018 | 14 of 193 | 2.1% | 6.1% | 23 | Held at last filing, Q2 2026 | +11% |
| IQV IQVIA HLDGS INC | Q4 2018 | 12 of 207 | 9.2% | 9.2% | 30 | Held at last filing, Q2 2026 | +66% |
| KBR KBR INC | Q2 2019 | 7 of 151 | 1.9% | 2.2% | 11 | Exited by Q1 2022 | +91% |
| KMB KIMBERLY CLARK CORP | Q2 2019 | 8 of 130 | 2.4% | 4.2% | 2 | Exited by Q4 2019 | +6.6% |
| IR INGERSOLL-RAND PLC | Q2 2019 | 14 of 131 | 2.4% | 2.4% | 2 | Exited by Q1 2020 | +6.0% |
| LMT LOCKHEED MARTIN CORP | Q2 2019 | 16 of 178 | 5.8% | 5.8% | 2 | Exited by Q4 2019 | +7.3% |
| LHX L3HARRIS TECHNOLOGIES INC | Q3 2019 | 2 of 160 | 4.4% | 4.4% | 4 | Exited by Q3 2020 | −19% |
| NVST ENVISTA HLDGS CORP | Q3 2019 | 5 of 137 | 0.2% | 1.1% | 2 | Exited by Q1 2020 | +6.3% |
| FICO FAIR ISAAC CORP | Q3 2019 | 13 of 186 | 0.5% | 1.1% | 2 | Exited by Q1 2020 | +23% |
| LYFT LYFT INC | Q3 2019 | 17 of 258 | 1.2% | 1.8% | 5 | Exited by Q2 2021 | +55% |
| SPCE VIRGIN GALACTIC HOLDINGS INC | Q4 2019 | 1 of 98 | 1.5% | 1.5% | 2 | Exited by Q2 2020 | +28% |
| GFL GFL ENVIRONMENTAL INC | Q1 2020 | 2 of 120 | 1.2% | 3.4% | 13 | Exited by Q3 2023 | +158% |
| STRO SUTRO BIOPHARMA INC | Q1 2020 | 7 of 82 | 0.02% | 1.9% | 23 | Exited by Q4 2025 | −91% |
| 4XC1 KALVISTA PHARMACEUTICALS INC | Q1 2020 | 9 of 91 | 0.02% | 2.6% | 25 | Exited by Q2 2026 | +163% |
| INSM INSMED INC | Q1 2020 | 12 of 180 | 0.03% | 6.9% | 23 | Exited by Q1 2026 | +986% |
| RPRX ROYALTY PHARMA PLC | Q2 2020 | 2 of 124 | 2.2% | 6.0% | 18 | Exited by Q4 2024 | −42% |
| OTIS OTIS WORLDWIDE CORP | Q2 2020 | 6 of 147 | 3.2% | 4.3% | 11 | Exited by Q1 2023 | +38% |
| APH AMPHENOL CORP | Q2 2020 | 9 of 186 | 1.5% | 1.8% | 3 | Held at last filing, Q2 2026 | +636% |
| MRNS* MARINUS PHARMACEUTICALS INC | Q3 2020 | 7 of 68 | 0.2% | 2.7% | 17 | Exited by Q4 2024 | – |
| GH GUARDANT HEALTH INC | Q3 2020 | 14 of 182 | 0.9% | 1.3% | 3 | Exited by Q2 2021 | +37% |
| OPEN OPENDOOR TECHNOLOGIES INC | Q4 2020 | 2 of 145 | 2.5% | 3.3% | 5 | Exited by Q1 2022 | −36% |
| 290A CHINOOK THERAPEUTICS INC | Q4 2020 | 6 of 77 | 0.1% | 3.6% | 11 | Exited by Q3 2023 | +142% |
| PWR QUANTA SVCS INC | Q4 2020 | 16 of 179 | 0.9% | 2.7% | 5 | Exited by Q1 2022 | +59% |
| EYPT EYEPOINT INC | Q1 2021 | 3 of 87 | 0.2% | 4.3% | 22 | Held at last filing, Q2 2026 | +41% |
| PSFE PAYSAFE LIMITED | Q1 2021 | 4 of 90 | 2.6% | 2.6% | 2 | Exited by Q3 2021 | −10% |
| FULC FULCRUM THERAPEUTICS INC | Q1 2021 | 5 of 95 | 0.3% | 1.9% | 22 | Held at last filing, Q2 2026 | −69% |
| 430 TERNS PHARMACEUTICALS INC | Q1 2021 | 6 of 138 | 0.4% | 2.6% | 12 | Exited by Q2 2024 | −70% |
| GLUE MONTE ROSA THERAPEUTICS INC | Q2 2021 | 6 of 83 | 0.05% | 1.9% | 10 | Held at last filing, Q2 2026 | +6.6% |
| HWM HOWMET AEROSPACE INC | Q2 2021 | 11 of 169 | 0.9% | 1.4% | 2 | Exited by Q4 2021 | −9.5% |
| MQ MARQETA INC | Q2 2021 | 12 of 127 | 0.2% | 1.4% | 4 | Exited by Q3 2022 | −71% |
| NTRA NATERA INC | Q2 2021 | 15 of 167 | 0.6% | 1.4% | 19 | Held at last filing, Q2 2026 | +139% |
| ACLXGBX ARCELLX INC | Q1 2022 | 2 of 105 | 0.7% | 6.2% | 11 | Exited by Q4 2024 | +1091% |
| COGT COGENT BIOSCIENCES INC | Q2 2022 | 9 of 121 | 0.2% | 1.6% | 8 | Exited by Q2 2024 | −26% |
| PROK PROKIDNEY CORP | Q3 2022 | 2 of 42 | 1.2% | 1.9% | 16 | Held at last filing, Q2 2026 | −77% |
| BHVN BIOHAVEN LTD | Q3 2022 | 3 of 126 | 0.02% | 9.3% | 16 | Held at last filing, Q2 2026 | +142% |
| CEG CONSTELLATION ENERGY CORP | Q4 2022 | 21 of 237 | 1.6% | 2.7% | 3 | Exited by Q3 2023 | +6.2% |
| ARQT ARCUTIS BIOTHERAPEUTICS INC | Q1 2023 | 8 of 102 | 0.4% | 8.7% | 14 | Held at last filing, Q2 2026 | +138% |
| ZURA ZURA BIO LTD | Q2 2023 | 2 of 70 | 1.3% | 1.5% | 13 | Held at last filing, Q2 2026 | −28% |
| AVBP ARRIVENT BIOPHARMA INC | Q1 2024 | 4 of 52 | 1.2% | 3.3% | 10 | Held at last filing, Q2 2026 | +95% |
| CTNM CONTINEUM THERAPEUTICS INC | Q2 2024 | 1 of 51 | 1.5% | 1.5% | 9 | Held at last filing, Q2 2026 | −6.9% |
| BIOA BIOAGE LABS INC | Q3 2024 | 3 of 61 | 1.1% | 1.1% | 3 | Exited by Q2 2025 | −82% |
| PVLA PALVELLA THERAPEUTICS INC NE | Q4 2024 | 2 of 54 | 0.3% | 3.9% | 7 | Held at last filing, Q2 2026 | +1174% |
| AURA AURA BIOSCIENCES INC | Q1 2025 | 5 of 47 | 0.6% | 1.1% | 6 | Held at last filing, Q2 2026 | +21% |
| FTH FAETH THERAPEUTICS INC | Q1 2026 | 2 of 28 | 0.03% | 1.1% | 2 | Held at last filing, Q2 2026 | −21% |